Solid Biosciences (SLDB) Capital Leases (2018 - 2024)
Quarterly results put Capital Leases at $307000.0 for Q3 2024, down 77.46% from a year ago — trailing twelve months through Sep 2024 was $307000.0 (down 77.46% YoY), and the annual figure for FY2023 was $1.2 million, down 27.54%.
Solid Biosciences has reported Capital Leases over the past 7 years, most recently at $307000.0 for Q3 2024.
- Capital Leases reached $307000.0 in Q3 2024 per SLDB's latest filing, down from $953000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $1.7 million in Q4 2022 and bottomed at $231000.0 in Q1 2022.
- Median Capital Leases over the past 5 years was $632000.0 (2020), compared with a mean of $818470.6.
- The largest annual shift saw Capital Leases soared 590.91% in 2023 before it crashed 77.46% in 2024.
- Over 5 years, Capital Leases stood at $525000.0 in 2020, then crashed by 44.19% to $293000.0 in 2021, then skyrocketed by 481.23% to $1.7 million in 2022, then dropped by 27.54% to $1.2 million in 2023, then tumbled by 75.12% to $307000.0 in 2024.
- Business Quant data shows Capital Leases for SLDB at $307000.0 in Q3 2024, $953000.0 in Q2 2024, and $1.1 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 307,000.00 |
| Jun 30, 2024 | 953,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 293,000.00 |
| Sep 30, 2021 | 353,000.00 |
| Jun 30, 2021 | 412,000.00 |
| Mar 31, 2021 | 469,000.00 |
| Dec 31, 2020 | 525,000.00 |
| Sep 30, 2020 | 579,000.00 |
| Jun 30, 2020 | 632,000.00 |
| Mar 31, 2020 | 683,000.00 |
| Dec 31, 2019 | 733,000.00 |
| Sep 30, 2019 | 782,000.00 |
| Jun 30, 2019 | 829,000.00 |
| Mar 31, 2019 | 813,000.00 |
| Dec 31, 2018 | 859,000.00 |